Eckert K G, Eyer P
Biochem Pharmacol. 1983 Mar 15;32(6):1019-27. doi: 10.1016/0006-2952(83)90620-2.
The metabolites of phenacetin, 2-hydroxyphenetidine and 4-nitrosophenetol, rapidly produced ferrihemoglobin both in vivo (dogs) and in vitro. At low concns, 2-hydroxyphenetidine was superior to 4-nitrosophenetol in ferrihemoglobin formation. The kinetics of ferrihemoglobin formation by 2-hydroxyphenetidine in solutions of purified human hemoglobin was biphasic and exhibited an unusual dose response. Similar to p-aminophenols, 2-hydroxyphenetidine was oxidized by oxyhemoglobin, and the oxidation product(s) were reduced by ferrohemoglobin with the formation of ferrihemoglobin. In addition, these oxidation products condensed to 2-amino-7-ethoxy-3H-phenoxazine-3-one (u.v., i.r., 1H-NMR and mass spectroscopy). This metabolite produced ferrihemoglobin by itself and was responsible for the slow phase of ferrihemoglobin formation observed with 2-hydroxyphenetidine. This condensation reaction, which was also observed with 2-aminophenol, prevented thioether formation of the transient o-quinonimines with the cysteine residues of hemoglobin and reduced glutathione as observed with 4-aminophenol and 4-dimethylaminophenol. Phenoxazone formation, which depends on the square of the o-quinonimine concn, was negligible at micromolar concns. At similar concns addition reactions to thiols prevailed also with 2-hydroxyphenetidine and 2-aminophenol. Other electrophilic reactions, e.g. with primary amino groups of amino acids, were insignificant. These dose-dependent differences in the reactions of isomeric aminophenols may explain the low nephrotoxicity of those o-aminophenols capable of forming phenoxazones when given in a single dose. This self-detoxication of some o-quinonimines, however, should not function during long-term exposure to repetitive low doses of such o-aminophenols.
非那西丁的代谢产物2-羟基苯乙胺和4-亚硝基苯乙醚,无论在体内(狗)还是体外都能迅速产生高铁血红蛋白。在低浓度时,2-羟基苯乙胺在高铁血红蛋白形成方面优于4-亚硝基苯乙醚。2-羟基苯乙胺在纯化的人血红蛋白溶液中形成高铁血红蛋白的动力学是双相的,并且表现出不寻常的剂量反应。与对氨基酚类似,2-羟基苯乙胺被氧合血红蛋白氧化,氧化产物被亚铁血红蛋白还原并形成高铁血红蛋白。此外,这些氧化产物缩合形成2-氨基-7-乙氧基-3H-吩恶嗪-3-酮(紫外、红外、1H-核磁共振和质谱)。这种代谢产物自身就能产生高铁血红蛋白,并且是2-羟基苯乙胺观察到的高铁血红蛋白形成慢相的原因。这种缩合反应在2-氨基酚中也能观察到,它阻止了与血红蛋白和谷胱甘肽的半胱氨酸残基形成硫醚,而4-氨基酚和4-二甲基氨基酚则会形成硫醚。吩恶嗪的形成取决于邻醌亚胺浓度的平方,在微摩尔浓度下可以忽略不计。在相似浓度下,2-羟基苯乙胺和2-氨基酚与硫醇的加成反应也占主导。其他亲电反应,如与氨基酸伯氨基的反应则不显著。这些异构体氨基酚反应中的剂量依赖性差异可能解释了那些单次给药时能够形成吩恶嗪的邻氨基酚肾毒性较低的原因。然而,一些邻醌亚胺的这种自我解毒作用在长期重复低剂量接触此类邻氨基酚时可能不起作用。